iBio Inc (IBIO)

Feb 28, 2025

iBio Inc. stock rises Friday, outperforms market - MarketWatch

Feb 28, 2025

Feb 27, 2025

iBio Inc. stock rises Thursday, outperforms market - MarketWatch

Feb 27, 2025

Feb 27, 2025

iBio stock soars to 52-week high, reaches $5.03 - Investing.com

Feb 27, 2025

Feb 27, 2025

iBio stock soars to 52-week high, reaches $5.03 By Investing.com - Investing.com South Africa

Feb 27, 2025

Feb 26, 2025

iBio Inc. stock falls Wednesday, underperforms market - MarketWatch

Feb 26, 2025

Feb 25, 2025

iBio Inc. stock rises Tuesday, outperforms market - MarketWatch

Feb 25, 2025

Feb 24, 2025

iBio Inc. stock falls Monday, still outperforms market - MarketWatch

Feb 24, 2025

Feb 22, 2025

iBio, Inc. Advances in Therapeutics and Leadership - TipRanks

Feb 22, 2025

Feb 21, 2025

iBio Inc. stock falls Friday, underperforms market - MarketWatch

Feb 21, 2025

Feb 20, 2025

iBio Inc. stock falls Thursday, underperforms market - MarketWatch

Feb 20, 2025

Feb 20, 2025

iBio to Begin Trading on the Nasdaq Stock Exchange - GlobeNewswire

Feb 20, 2025

Feb 19, 2025

iBio Inc. stock rises Wednesday, outperforms market - MarketWatch

Feb 19, 2025

Feb 19, 2025

iBio Announces Transfer to Nasdaq Capital Market - TipRanks

Feb 19, 2025

Feb 19, 2025

Can iBio's Nasdaq Move Transform Its Market Presence? Key Details Revealed - StockTitan

Feb 19, 2025

Feb 17, 2025

Is Ibio, Inc. (IBIO) Among Stocks Insiders Are Buying This Year? - Insider Monkey

Feb 17, 2025

Feb 17, 2025

10 Stocks Insiders Are Buying This Year - Insider Monkey

Feb 17, 2025

Feb 12, 2025

Ibio Inc Faces Financial Risk from Potential Stockholder Equity Dilution and Capital Raising Challenges - TipRanks

Feb 12, 2025

Feb 11, 2025

iBio Inc. stock falls Tuesday, underperforms market - MarketWatch

Feb 11, 2025

Feb 11, 2025

SEC Form 424B3 filed by iBio Inc. - Quantisnow

Feb 11, 2025

Feb 10, 2025

iBio Inc. stock falls Monday, underperforms market - MarketWatch

Feb 10, 2025

Feb 10, 2025

iBio Inc. (IBIO) reports earnings - Quartz

Feb 10, 2025

Feb 10, 2025

iBio, Inc. Reports Second Quarter Fiscal 2025 Financial Results and Corporate Updates on Advancements in Cardiometabolic Therapeutics - Nasdaq

Feb 10, 2025

Feb 10, 2025

iBio Reports Fiscal Second Quarter 2025 Financial Results - GlobeNewswire

Feb 10, 2025

Feb 10, 2025

IBIO's Strategic Pivot: AI-Powered Antibody Discovery Shows Promise Despite Q2 Losses - StockTitan

Feb 10, 2025

Feb 07, 2025

A Tale of Resilience: iBio Inc Amid Stock Market Turbulence - The InvestChronicle

Feb 07, 2025

Feb 07, 2025

iBio (IBIO) Projected to Post Quarterly Earnings on Friday - Defense World

Feb 07, 2025

Feb 04, 2025

iBio (NYSE:IBIO) Trading Up 4% – Time to Buy? - Defense World

Feb 04, 2025

Feb 04, 2025

iBio (NYSEMKT:IBIO) Trading Up 1.3% – Still a Buy? - Defense World

Feb 04, 2025

Feb 03, 2025

iBio Inc. stock rises Monday, outperforms market - MarketWatch

Feb 03, 2025

Jan 16, 2025

I: Weekly TechBio News - substack.com

Jan 16, 2025

Jan 15, 2025

iBio Announces Successful Closing of Private Placement OfferingOn January 10, 2025, iBio, Inc. (NYSE American: IBIO) announced the completion of a private placement offering, marking an important development for the company. The securities purchase a - Defense World

Jan 15, 2025

Jan 14, 2025

Felipe Duran Increases Stake in iBio Inc with Recent Share Purch - GuruFocus.com

Jan 14, 2025

Jan 13, 2025

iBio director Parada acquires $499,998 in common stock By Investing.com - Investing.com Australia

Jan 13, 2025

Jan 13, 2025

iBio director William Clark purchases $4,999 in common stock By Investing.com - Investing.com Australia

Jan 13, 2025

Jan 13, 2025

Director David Arkowitz Acquires 18,382 Shares of iBio Inc (IBIO) - GuruFocus.com

Jan 13, 2025